NEUROENDOCRINE TUMORS
Clinical trials for NEUROENDOCRINE TUMORS explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMORS trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising cancer treatment study halted early after recruiting just one patient
Disease control TerminatedThis study aimed to see if giving a radioactive drug called Lutathera after surgery could delay the return of neuroendocrine tumors that had spread to the liver. It compared Lutathera to standard monitoring in people whose tumors were completely or nearly completely removed. Only…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 26, 2026 06:05 UTC
-
Experimental drug studied for rare gut tumors, trial stopped early
Disease control TerminatedThis study tested a drug called entinostat in people with advanced abdominal neuroendocrine tumors that had come back or stopped responding to other treatments. Only 5 participants were enrolled before the trial was ended early. The goal was to see if the drug could shrink tumors…
Matched conditions: NEUROENDOCRINE TUMORS
Phase: PHASE2 • Sponsor: Antonio Fojo • Aim: Disease control
Last updated May 26, 2026 05:49 UTC